BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32643877)

  • 1. Identification of paternal germline mosaicism by MicroSeq and targeted next-generation sequencing.
    Dai C; Cheng D; Li W; Zeng S; Lu G; Zhang Q
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1394. PubMed ID: 32643877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low frequency of parental mosaicism in de novo COL4A5 mutations in X-linked Alport syndrome.
    Helle OMB; Pedersen TH; Ousager LB; Thomassen M; Hertz JM
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1452. PubMed ID: 32812400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next generation sequencing as a useful tool in the diagnostics of mosaicism in Alport syndrome.
    Beicht S; Strobl-Wildemann G; Rath S; Wachter O; Alberer M; Kaminsky E; Weber LT; Hinrichsen T; Klein HG; Hoefele J
    Gene; 2013 Sep; 526(2):474-7. PubMed ID: 23732293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Female X-linked Alport syndrome with somatic mosaicism.
    Yokota K; Nozu K; Minamikawa S; Yamamura T; Nakanishi K; Kaneda H; Hamada R; Nozu Y; Shono A; Ninchoji T; Morisada N; Ishimori S; Fujimura J; Horinouchi T; Kaito H; Nakanishi K; Morioka I; Taniguchi-Ikeda M; Iijima K
    Clin Exp Nephrol; 2017 Oct; 21(5):877-883. PubMed ID: 27796712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic mosaicism and variant frequency detected by next-generation sequencing in X-linked Alport syndrome.
    Fu XJ; Nozu K; Kaito H; Ninchoji T; Morisada N; Nakanishi K; Yoshikawa N; Ohtsubo H; Matsunoshita N; Kamiyoshi N; Matsumura C; Takagi N; Maekawa K; Taniguchi-Ikeda M; Iijima K
    Eur J Hum Genet; 2016 Mar; 24(3):387-91. PubMed ID: 26014433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case with somatic and germline mosaicism in COL4A5 detected by multiplex ligation-dependent probe amplification in X-linked Alport syndrome.
    Aoto Y; Kise T; Nakanishi K; Nagano C; Horinouchi T; Yamamura T; Ishiko S; Sakakibara N; Shima Y; Morisada N; Iijima K; Nozu K
    CEN Case Rep; 2020 Nov; 9(4):431-436. PubMed ID: 32621070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome.
    Zhang Y; Ding J; Zhang H; Yao Y; Xiao H; Wang S; Wang F
    Mol Genet Genomic Med; 2019 May; 7(5):e647. PubMed ID: 30883042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expert consensus guidelines for the genetic diagnosis of Alport syndrome.
    Savige J; Ariani F; Mari F; Bruttini M; Renieri A; Gross O; Deltas C; Flinter F; Ding J; Gale DP; Nagel M; Yau M; Shagam L; Torra R; Ars E; Hoefele J; Garosi G; Storey H
    Pediatr Nephrol; 2019 Jul; 34(7):1175-1189. PubMed ID: 29987460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alport syndrome: impact of digenic inheritance in patients management.
    Fallerini C; Baldassarri M; Trevisson E; Morbidoni V; La Manna A; Lazzarin R; Pasini A; Barbano G; Pinciaroli AR; Garosi G; Frullanti E; Pinto AM; Mencarelli MA; Mari F; Renieri A; Ariani F
    Clin Genet; 2017 Jul; 92(1):34-44. PubMed ID: 27859054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted exome sequencing integrated with clinicopathological information reveals novel and rare mutations in atypical, suspected and unknown cases of Alport syndrome or proteinuria.
    Chatterjee R; Hoffman M; Cliften P; Seshan S; Liapis H; Jain S
    PLoS One; 2013; 8(10):e76360. PubMed ID: 24130771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving mutation screening in familial hematuric nephropathies through next generation sequencing.
    Morinière V; Dahan K; Hilbert P; Lison M; Lebbah S; Topa A; Bole-Feysot C; Pruvost S; Nitschke P; Plaisier E; Knebelmann B; Macher MA; Noel LH; Gubler MC; Antignac C; Heidet L
    J Am Soc Nephrol; 2014 Dec; 25(12):2740-51. PubMed ID: 24854265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Cryptic Mosaicism in X-linked Alport Syndrome Prompts to Re-evaluate Living-donor Kidney Transplantation.
    Pinto AM; Daga S; Fallerini C; Bruttini M; Baldassarri M; Giliberti A; Frullanti E; Guarnieri A; Garosi G; Renieri A
    Transplantation; 2020 Nov; 104(11):2360-2364. PubMed ID: 31895869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadal mosaicism as a rare cause of autosomal recessive inheritance.
    Anazi S; Al-Sabban E; Alkuraya FS
    Clin Genet; 2014 Mar; 85(3):278-81. PubMed ID: 23551117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal diagnosis of Duchenne muscular dystrophy revealed a novel mosaic mutation in Dystrophin gene: a case report.
    Wang Y; Chen Y; Wang SM; Liu X; Gu YN; Feng Z
    BMC Med Genet; 2020 Nov; 21(1):222. PubMed ID: 33176713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Value of Parental Testing by Next-Generation Sequencing Includes the Detection of Germline Mosaicism.
    Brewer CJ; Gillespie M; Fierro J; Scaringe WA; Li JM; Lee CY; Yen HY; Gao H; Strom SP
    J Mol Diagn; 2020 May; 22(5):670-678. PubMed ID: 32092540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline mosaicism is a pitfall in the diagnosis of "sporadic" X-linked Alport syndrome.
    Okamoto T; Nozu K; Iijima K; Ariga T
    J Nephrol; 2019 Feb; 32(1):155-159. PubMed ID: 30062677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Permanent neonatal diabetes due to paternal germline mosaicism for an activating mutation of the KCNJ11 Gene encoding the Kir6.2 subunit of the beta-cell potassium adenosine triphosphate channel.
    Gloyn AL; Cummings EA; Edghill EL; Harries LW; Scott R; Costa T; Temple IK; Hattersley AT; Ellard S
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3932-5. PubMed ID: 15292329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compound Mutations of the COL4A3 including a Novel Allele Identified in a Patient with Alport Syndrome.
    Wang Z; Jiang B; Jin S; Hu Z; Liu G
    Biomed Res Int; 2020; 2020():1626378. PubMed ID: 33524082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A founder mutation in COL4A3 causes autosomal recessive Alport syndrome in the Ashkenazi Jewish population.
    Webb BD; Brandt T; Liu L; Jalas C; Liao J; Fedick A; Linderman MD; Diaz GA; Kornreich R; Trachtman H; Mehta L; Edelmann L
    Clin Genet; 2014 Aug; 86(2):155-60. PubMed ID: 23927549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.